Cargando…

Cognition in the Early Stage of Type 2 Diabetes

OBJECTIVE: Type 2 diabetes is known to be associated with decrements in memory and executive functions and information-processing speed. It is less clear, however, at which stage of diabetes these cognitive decrements develop and how they progress over time. In this study, we investigated cognitive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruis, Carla, Biessels, Geert Jan, Gorter, Kees J., van den Donk, Maureen, Kappelle, L. Jaap, Rutten, Guy E.H.M.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2009
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699741/ https://www.ncbi.nlm.nih.gov/pubmed/19366968 http://dx.doi.org/10.2337/dc08-2143

Ejemplares similares

Cognitive Impairment in Diabetes: Rationale and Design Protocol of the Cog-ID Study
por: Koekkoek, Paula S, et al.
Publicado: (2015)

Combined Task Delegation, Computerized Decision Support, and Feedback Improve Cardiovascular Risk for Type 2 Diabetic Patients: A cluster randomized trial in primary care
por: Cleveringa, Frits G.W., et al.
Publicado: (2008)

No negative effects of a multi-factorial, intensified treatment on self-reported health status, treatment satisfaction, and diabetes-related distress in screen-detected type 2 diabetes patients. The ADDITION-Netherlands study
por: van den Donk, Maureen, et al.
Publicado: (2010)

Depressive symptoms and quality of life after screening for cognitive impairment in patients with type 2 diabetes: observations from the Cog-ID cohort study
por: Janssen, Jolien, et al.
Publicado: (2019)

People with type 2 diabetes and screen-detected cognitive impairment use acute health care services more often: observations from the COG-ID study
por: Janssen, Jolien, et al.
Publicado: (2019)

Towards a more efficient diabetes control in primary care: six-monthly monitoring compared with three-monthly monitoring in type 2 diabetes - The EFFIMODI trial. Design of a randomised controlled patient-preference equivalence trial in primary care
por: Wermeling, Paulien R, et al.
Publicado: (2010)

Cost-Effectiveness of the Diabetes Care Protocol, a Multifaceted Computerized Decision Support Diabetes Management Intervention That Reduces Cardiovascular Risk
por: Cleveringa, Frits G.W., et al.
Publicado: (2010)

How to choose the most appropriate cognitive test to evaluate cognitive complaints in primary care
por: Janssen, Jolien, et al.
Publicado: (2017)

Potentials of incretin‐based therapies in dementia and stroke in type 2 diabetes mellitus
por: Groeneveld, Onno N, et al.
Publicado: (2015)

Satisfaction of well-controlled type 2 diabetes patients with three-monthly and six-monthly monitoring
por: Wermeling, Paulien R, et al.
Publicado: (2013)

Both cardiovascular and non-cardiovascular comorbidity are related to health status in well-controlled type 2 diabetes patients: a cross-sectional analysis
por: Wermeling, Paulien R, et al.
Publicado: (2012)

Advanced glycation end products measured by skin autofluorescence in a population with central obesity
por: den Engelsen, Corine, et al.
Publicado: (2012)

Remission of screen-detected metabolic syndrome and its determinants: an observational study
por: den Engelsen, Corine, et al.
Publicado: (2012)

Microstructural White Matter Abnormalities and Cognitive Functioning in Type 2 Diabetes: A diffusion tensor imaging study
por: Reijmer, Yael D., et al.
Publicado: (2013)

Three years follow-up of screen-detected diabetic and non-diabetic subjects: who is better off? The ADDITION Netherlands study
por: Janssen, Paul GH, et al.
Publicado: (2008)

High-sensitivity C-reactive protein to detect metabolic syndrome in a centrally obese population: a cross-sectional analysis
por: den Engelsen, Corine, et al.
Publicado: (2012)

Tailored support for type 2 diabetes patients with an acute coronary event after discharge from hospital – design and development of a randomised controlled trial
por: Kasteleyn, Marise J, et al.
Publicado: (2014)

Disruption of the Cerebral White Matter Network Is Related to Slowing of Information Processing Speed in Patients With Type 2 Diabetes
por: Reijmer, Yael D., et al.
Publicado: (2013)

Brain MRI Correlates of Cognitive Dysfunction in Type 2 Diabetes: The Needle Recovered From the Haystack?
por: Biessels, Geert Jan
Publicado: (2013)

Defining and improving quality management in Dutch diabetes care groups and outpatient clinics: design of the study
por: Campmans-Kuijpers, Marjo JE, et al.
Publicado: (2013)

Nonfocal transient neurological attacks are related to cognitive impairment in patients with heart failure
por: Oudeman, Eline A., et al.
Publicado: (2019)

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial
por: Griffin, Simon J, et al.
Publicado: (2011)

Perfusion CT in suspected ischaemic stroke: red flags that should have been blue
por: Huisman, Mark H. B., et al.
Publicado: (2010)

Shared decision making in type 2 diabetes with a support decision tool that takes into account clinical factors, the intensity of treatment and patient preferences: design of a cluster randomised (OPTIMAL) trial
por: den Ouden, Henk, et al.
Publicado: (2015)

Progression of Cerebral Atrophy and White Matter Hyperintensities in Patients With Type 2 Diabetes
por: de Bresser, Jeroen, et al.
Publicado: (2010)

Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes
por: Manschot, S. M., et al.
Publicado: (2007)

Cerebral perfusion in relation to cognitive function and type 2 diabetes
por: Tiehuis, A. M., et al.
Publicado: (2008)

A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus
por: van den Berg, E., et al.
Publicado: (2009)

Determinants of leptomeningeal collateral flow in stroke patients with a middle cerebral artery occlusion
por: van Seeters, Tom, et al.
Publicado: (2016)

Risk evaluation of cognitive impairment in patients with heart failure: A call for action
por: Kuipers, Sanne, et al.
Publicado: (2022)

Lower haemoglobin concentrations are associated with impaired cognition in patients with carotid artery occlusion
por: Kuipers, Sanne, et al.
Publicado: (2023)

Microbleeds colocalize with enlarged juxtacortical perivascular spaces in amnestic mild cognitive impairment and early Alzheimer’s disease: A 7 Tesla MRI study
por: Bouvy, Willem H, et al.
Publicado: (2019)

Cognitive dysfunction in diabetes: how to implement emerging guidelines
por: Biessels, Geert J., et al.
Publicado: (2019)

Cerebral cortical microinfarcts in patients with internal carotid artery occlusion
por: van den Brink, Hilde, et al.
Publicado: (2021)

Shared and distinct anatomical correlates of semantic and phonemic fluency revealed by lesion-symptom mapping in patients with ischemic stroke
por: Biesbroek, J. Matthijs, et al.
Publicado: (2015)

Rationale and design of the CAROLINA® - cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus
por: Biessels, Geert Jan, et al.
Publicado: (2018)

Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study
por: Biessels, Geert Jan, et al.
Publicado: (2021)

Completeness of the circle of Willis and risk of ischemic stroke in patients without cerebrovascular disease
por: van Seeters, Tom, et al.
Publicado: (2015)

Diagnosing vascular cognitive impairment: Current challenges and future perspectives
por: Biesbroek, J Matthijs, et al.
Publicado: (2022)

HbA(1c), Insulin Resistance, and β-Cell Function in Relation to Cognitive Function in Type 2 Diabetes: The CAROLINA Cognition Substudy
por: Janssen, Jolien, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_g3lru8ssidber3p6tc5krt4cg0